What happened: MPs and ministers have raised concerns that the UK’s recent pharmaceutical agreement with the US, announced as tariff-free, lacks a formal legal text beyond initial press statements. The deal could lead to higher NHS medicine costs without clear protections.
Why it matters:
- Potentially higher costs for NHS medicines may impact public healthcare budgets.
- Uncertainty over the deal’s legal status could expose UK taxpayers to financial risks.
MNN Take: The UK government’s reliance on informal agreements with the US raises questions about the security and clarity of trade deals, especially when public funds and healthcare services are involved.
Sources: Guardian UK